267 related articles for article (PubMed ID: 25830680)
1. Co-processed chitin-mannitol as a new excipient for Oro-dispersible tablets.
Daraghmeh N; Chowdhry BZ; Leharne SA; Al Omari MM; Badwan AA
Mar Drugs; 2015 Mar; 13(4):1739-64. PubMed ID: 25830680
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of a novel co-processed excipient of chitin and crystalline mannitol.
Daraghmeh N; Rashid I; Al Omari MM; Leharne SA; Chowdhry BZ; Badwan A
AAPS PharmSciTech; 2010 Dec; 11(4):1558-71. PubMed ID: 21052880
[TBL] [Abstract][Full Text] [Related]
3. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
[TBL] [Abstract][Full Text] [Related]
4. Fast and pH-dependent release of domperidone from orally disintegrating tablets.
Assaf SM; Qandil AM; Al-Ani EA
Pharm Dev Technol; 2013; 18(4):897-905. PubMed ID: 22304659
[TBL] [Abstract][Full Text] [Related]
5. Development of Coprocessed Chitin-Calcium Carbonate as Multifunctional Tablet Excipient for Direct Compression.
Chaheen M; Sanchez-Ballester NM; Bataille B; Yassine A; Belamie E; Sharkawi T
J Pharm Sci; 2018 Aug; 107(8):2152-2159. PubMed ID: 29698724
[TBL] [Abstract][Full Text] [Related]
6. Effect of co-processed excipient type on properties of orodispersible tablets containing captopril, tramadol, and domperidone.
Tranová T; Loskot J; Navrátil O; Brniak W; Mužíková J
Int J Pharm; 2023 Apr; 636():122838. PubMed ID: 36921743
[TBL] [Abstract][Full Text] [Related]
7. Formulation, development, and performance evaluation of metoclopramide HCl oro-dispersible sustained release tablet.
Kasliwal N; Negi JS; Jugran V; Jain R
Arch Pharm Res; 2011 Oct; 34(10):1691-700. PubMed ID: 22076769
[TBL] [Abstract][Full Text] [Related]
8. Understanding the Performance of a Novel Direct Compression Excipient Comprising Roller Compacted Chitin.
Abu Fara D; Al-Hmoud L; Rashid I; Chowdhry BZ; Badwan A
Mar Drugs; 2020 Feb; 18(2):. PubMed ID: 32079246
[TBL] [Abstract][Full Text] [Related]
9. Formulation and evaluation of a montelukast sodium orally disintegrating tablet with a similar dissolution profile as the marketed product.
Chen Y; Feng T; Li Y; Du B; Weng W
Pharm Dev Technol; 2017 Mar; 22(2):168-172. PubMed ID: 26654222
[TBL] [Abstract][Full Text] [Related]
10. Dissolution enhancement of tadalafil by liquisolid technique.
Lu M; Xing H; Yang T; Yu J; Yang Z; Sun Y; Ding P
Pharm Dev Technol; 2017 Feb; 22(1):77-89. PubMed ID: 27268461
[TBL] [Abstract][Full Text] [Related]
11. Formulation and development of orodispersible sustained release tablet of domperidone.
Patil HG; Tiwari RV; Repka MA; Singh KK
Drug Dev Ind Pharm; 2016; 42(6):906-15. PubMed ID: 26472165
[TBL] [Abstract][Full Text] [Related]
12. Influence of Chitin Source and Polymorphism on Powder Compression and Compaction: Application in Drug Delivery.
Al-Hmoud L; Abu Fara D; Rashid I; Chowdhry BZ; Badwan AA
Molecules; 2020 Nov; 25(22):. PubMed ID: 33198143
[TBL] [Abstract][Full Text] [Related]
13. [Preparation and application on compound excipient of sodium stearyl fumarate and plasdone S-630].
Jiang YR; Zhang ZH; Jia XB
Yao Xue Xue Bao; 2013 Jan; 48(1):125-30. PubMed ID: 23600153
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation and in vivo performance of lyophilized gliclazide.
Mansour HF; Aly UF
Drug Dev Ind Pharm; 2015 Apr; 41(4):650-7. PubMed ID: 24568609
[TBL] [Abstract][Full Text] [Related]
15. The enhanced aerosol performance of salbutamol from dry powders containing engineered mannitol as excipient.
Kaialy W; Martin GP; Ticehurst MD; Momin MN; Nokhodchi A
Int J Pharm; 2010 Jun; 392(1-2):178-88. PubMed ID: 20363301
[TBL] [Abstract][Full Text] [Related]
16. Development of Coprocessed Chitin-Calcium Carbonate as Multifunctional Tablet Excipient for Direct Compression, Part 2: Tableting Properties.
Chaheen M; Bataille B; Yassine A; Belamie E; Sharkawi T
J Pharm Sci; 2019 Oct; 108(10):3319-3328. PubMed ID: 31145923
[TBL] [Abstract][Full Text] [Related]
17. Influence of protein on mannitol polymorphic form produced during co-spray drying.
Hulse WL; Forbes RT; Bonner MC; Getrost M
Int J Pharm; 2009 Dec; 382(1-2):67-72. PubMed ID: 19682563
[TBL] [Abstract][Full Text] [Related]
18. Influence of Prosolv and Prosolv:Mannitol 200 direct compression fillers on the physicomechanical properties of atorvastatin oral dispersible tablets.
Gowda V; Pabari RM; Kelly JG; Ramtoola Z
Pharm Dev Technol; 2015 Jun; 20(4):394-400. PubMed ID: 24397821
[TBL] [Abstract][Full Text] [Related]
19. IDENTIFICATION OF PHARMACEUTICAL EXCIPIENT BEHAVIOR OF CHICKPEA (CICER ARIETINUM) STARCH IN GLICLAZIDE IMMEDIATE RELEASE TABLETS.
Meka VS; Yee P; Sheshala R
Acta Pol Pharm; 2016; 73(2):469-78. PubMed ID: 27180440
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of multi-component tablets containing co-amorphous salts: Combining multimodal non-linear optical imaging with established analytical methods.
Ojarinta R; Saarinen J; Strachan CJ; Korhonen O; Laitinen R
Eur J Pharm Biopharm; 2018 Nov; 132():112-126. PubMed ID: 30248394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
